Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1

Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1

The identification of universal tumor-specific antigens shared between multiple patients and/or multiple tumors is of great importance to overcome the practical limitations of personalized cancer immunotherapy. Recent studies support the involvement of DEPDC1 in many aspects of cancer traits, such a...

Full description

Bibliographic Details
Main Authors: Anna Tosi, Silvia Dalla Santa, Elisa Cappuzzello, Carolina Marotta, Dawid Walerich, Giannino Del Sal, Paola Zanovello, Roberta Sommaggio, Antonio Rosato
Format: Article
Language:English
Published: Taylor & Francis Group 2017-08-01
Series:OncoImmunology
Subjects:
cancer immunotherapy
cytotoxic t lymphocytes
depdc1
tumor antigen
triple negative breast cancer
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1313371

Internet

http://dx.doi.org/10.1080/2162402X.2017.1313371

Similar Items